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A B S T R A C T
The objective of this study was to assess current
infection control practice in Europe and its
structure, future research priorities, and how
infection control should be organised. A ques-
tionnaire was sent to 223 hospital infection
control physicians throughout Europe, of whom
54 in 18 countries responded. With respect to
future research priorities in infection control in
Europe, the largest proportion (69%) of the
infection control specialists sampled expressed
the need for standardisation of surveillance
systems for international comparison of nosoco-
mial infection rates. The results of this survey
might help to create a basis for standardised
guidelines which take into account European-
wide interests.
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During the past 10 years, the general setting for
the management of many European hospitals has
undergone enormous changes in economic, per-
sonnel and technical resources, frequently ignor-
ing the needs of small specialist units. At the same
time, the problem of nosocomial infections has
risen significantly. Obviously, new diagnostic and
therapeutic approaches have changed the patient
population, but the increasing problems are also
associated with the rise in bacterial resistance—a
problem rooted in the widespread, uncontrolled
and, in many cases, erroneous use of antibiotics,
coupled with inadequate hospital hygiene and the
lack of guidelines and ⁄ or commitment to existing
guidelines. Infection control is the key factor in
the prevention of nosocomial infections. A well-
organised department of hospital hygiene and
infection control can optimise the use of financial
resources, and effectively prevent (one-third of)
nosocomial infections. Unfortunately, at present,
European standards for the structure of hospital
infection control programmes are lacking.
In order to assess current infection control
practice and structure, future research priorities,
and how infection control should be organised, a
questionnaire was sent to 223 leading European
hospital infection control physicians selected from
the scientific literature. Part 1 concerned future
research priorities in hospital infection control;
part 2 the organisation of infection control; and
part 3 the demographics of the participating
hospitals and the respective infection control
departments. The contents of the questionnaire
are described below and in Tables 1 and 2.
The questionnaire was completed and returned
by 54 leading opinion leaders in hospital infection
control in 18 countries. By country, the distribu-
tion of responses received was as follows: Ger-
many, seven; The Netherlands, five; Greece, five;
Croatia, five; Slovenia, five; UK, four; France,
four; Turkey, three; Spain, three; Austria, two;
Belgium, two; Poland, two; Italy, two; Ireland,
one; Slovakia, one; Russia, one; Portugal, one; and
Bulgaria, one.
The hospital demographic data revealed that
the mean length of stay ranged from 6 to 9 days,
with no significant difference according to hospi-
tal size. The number of infection control nurses or
practitioners increased from 1.2 to 1.5 and 3.4 in
hospitals with < 400, 400–600 and > 600 beds,
respectively. In general, infection control nurses
had more work experience in the larger hospitals.
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The mean durations of duty in infection control
units were 8, 12 and 13.6 years, respectively, in
the above mentioned size categories of hospitals.
Only one-quarter of the infection control nurses
worked full-time.
In terms of research priorities, most (69%)
infection control specialists sampled expressed
the need for standardisation of surveillance sys-
tems for international comparison of nosocomial
infection rates in order to identify differences in
healthcare, and areas requiring improvement
(Table 1). Similarly, 65% of respondents saw the
need to develop methods to improve the appro-
priateness of antimicrobial use, and 60% would
support interventions to decrease the prevalence
of antimicrobial resistance in healthcare institu-
tions. Research concerning the impact of water-
borne nosocomial infections (including
legionellosis) and the development of epidemio-
logical tools for understanding the microbial
ecology of the hospital was accorded the lowest
priority (£ 40%; Table 1).
Asked how infection control should be organ-
ised in Europe, 83% of the specialists expressed
the need for one infection control nurse ⁄ 250 beds,
while 38% expressed the need for a full-time
hospital epidemiologist ⁄ 500 beds. Of the epide-
miologists sampled, 77% saw the need for formal
practical and theoretical training leading to an
approved degree and qualification on a Euro-
pean-wide basis.
More than half of the respondents preferred
focused incidence studies (for a certain period, or
in certain patient populations, or directed to a
certain nosocomial infection) to hospital-wide
and ⁄ or continued surveillance. Fewer than half
would participate in a yearly national prevalence
study (Table 2).
Of the hospitals surveyed, 94.5% implemented
written infection control guidelines that included
sections on personnel hygiene, hand hygiene,
isolation and wound care. Generally, the smallest
hospitals had no written guidelines. Nearly 53%
of respondents believed that routine surface dis-
infection of floors and toilet facilities was unnec-
essary and did not recommend this practice.
Beaujean et al. [1] recently compared the organ-
isation and implementation of infection control
practices in ten hospitals in seven European
countries. Striking differences were found in the
organisation of infection control programmes and
infection control practices throughout Europe. The
Table 1. Ranking of future research
priorities by 54 European infection
control opinion leaders
% of respondents
Standardisation of surveillance systems for international comparison of
nosocomial infection rates to identify differences in healthcare practices
and identify areas needing improvement
69
Development of methods to improve the appropriateness of antimicrobial use 65
Interventions that decrease the prevalence of antimicrobial resistance in
healthcare institutions
60
Evaluation of the utility of computerised healthcare information systems as
a resource for conducting surveillance of nosocomial infections
58
Creation of financial packaging systems for infection control use, which help
infection control practitioners display to hospital administrators the financial
and medical benefits possible from infection control and hospital epidemiology
56
Development of a European curriculum for hospital epidemiology 56
Determination of risk factors for resistance, including the relationship between
the use and ⁄ or volume of antibiotics and the introduction of antibiotic-resistant
organisms from the community
56
Application of behavioural and management sciences to achieve compliance
with infection prevention policies
56
Development of meaningful surveillance indicators for measuring nosocomial
infectious complications and defining standards for each indicator
52
Research on the cost–benefit and cost-effectiveness of interventions to
decrease nosocomial infections
52
Research on cost, morbidity and mortality from nosocomial infections 48
Development of methods to improve the clinical diagnosis, prevention and
management of ventilator-associated pneumonia
46
Identification of specific components of infection prevention and control
programmes and staffing in healthcare institutions which are effective and
cost-effective in reducing rates of infection
46
Studies of the effect of surface disinfectants on the prevention of
cross-transmission of methicillin-resistant Staphylococcus aureus,
vancomycin-resistant enterococci or Clostridium difficile
44
Studies of the relationship between healthcare workers’ workload and risk of
nosocomial infections and cross-transmission of nosocomial pathogens
42
Development of epidemiological tools for the understanding of microbial ecology
in hospitals
40
Evaluation of the impact of water-borne nosocomial infections, including those
caused by legionellae and fungi
33
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lack of consensus in Europe was illustrated by the
many variations in policies for preventing the
spread of tuberculosis and methicillin-resistant
Staphylococcus aureus. The establishment of a
European office to facilitate the exchange of exper-
tise and information to define basic requirements
and guidelines for infection control practices was
therefore recommended. One of the main tasks of
such a European Centre for Disease Control and
Prevention would be the organisation of surveil-
lance of hospital-acquired infection, which in the
present survey was given the highest priority for
future research in hospital infection control in
Europe. By comparing surveillance systems in
England, Germany and The Netherlands, Coello
et al. [2] found marked differences in the use of
definitions, study populations and follow-up,
although all three surveillance programmes were
based on the system used in the USA and shared
many features. For international comparison of
rates, these surveillance systems need further
standardisation. In the present survey, the devel-
opment of methods to improve antimicrobial use,
and interventions to decrease antimicrobial resist-
ance, were accorded the second highest priority in
the list of research priorities in Europe (65%;
Table 1). The European opinion leaders ranked
these research priorities in exactly the same order
as an international multidisciplinary panel of
experts, which was consulted in 2000 by a research
foundation for the prevention of complications
associated with healthcare [3].
We are aware that the methodology applied in
this study has its limitations. Nevertheless, we
conclude that professionalisation of infection
control in Europe, with a focus on standardisation
of surveillance systems, and the improvement of
antimicrobial use to decrease the prevalence of
antimicrobial resistance, is essential. European
opinion leaders in infection control all recom-
mend formal training and subsequent examina-
tion under the supervision of an authorised
institution of infection control doctors, leading
to a degree recognised and approved on a
European-wide basis [4–14].
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